The Immune Thrombocytopenia Syndrome: A Disorder of Diverse Pathogenesis and Clinical Presentation

Hematology/Oncology Clinics of North America

Volumn 23, Issue 6, 2009, Pages 1155-1161

  Cines, Douglas B ^a   Liebman, Howard A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Immune tolerance; ITP; Thrombocytopenia

Indexed keywords

CD20 ANTIBODY; CORTICOSTEROID; DEXAMETHASONE; IMMUNOGLOBULIN; RHESUS D ANTIBODY; THROMBOCYTE ANTIBODY;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; CELL DESTRUCTION; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOREGULATION; MEGAKARYOCYTE; MORBIDITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PURPURA; REMISSION; REVIEW; SPLENECTOMY; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTOPOIESIS;

HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; IMMUNE TOLERANCE; SYNDROME; THROMBOCYTOPENIA;

EID: 70449657870     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.09.003     Document Type: Review

References (23)

1. Werlhof PG. Disquisitio medica et philologica de variolis et anthracibus. Hannover, 1735 [in Latin].
2. Mueller-Eckhardt C. Idiopathic thrombocytopenic purpura (ITP): clinical and immunologic considerations. Semin Thromb Hemost 3 (1977) 125
3. Frank E. Die Essentielle Thrombopenia (Konstitutionelle purpura-Pseudohamophilie). I. Klinische Bild. H. Pathogenese. Berl Klin Wochenschr 52 (1915) 454 [in German]
4. Kaznelson P. Verschwinden der hamorrhagischen diathese bei einem Falle von "essentieller Thrombopenie" (FRANK) nach Milzexstirpation. Splenogene thrombolytische Purpura. Wien Klin Wochenschr 29 (1916) 1451 [in German]
5. Dameshek W., and Miller E.B. The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood 1 (1946) 27
6. Evans R.S., Takahashi R.T., Duane R.T., et al. Primary thrombocytopenic purpura and acquired hemolytic anemia: evidence for a common etiology. Arch Intern Med 87 (1951) 48-65
7. Harrington W.J., Minnich V., Hollingworth J.W., et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38 (1951) 1-10
8. Shulman N.R., Marder V., and Weinrach R. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic thrombocytopenic purpura. Physiologic, serologic and isotopic studies. Ann N Y Acad Sci 124 (1965) 499-542
9. Harrington W.J., Sprague C., Minnich V., et al. Immunologic mechanism in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med 38 (1953) 433-438
10. Fujisawa K., Tani P., O'Toole T.E., et al. Different specificities of platelet-associated and plasma autoantibodies to platelet GPIIb-IIIa in patients with chronic immune thrombocytopenic purpura. Blood 79 (1992) 1441-1446
11. Stoll D., Cines D.B., Aster R.H., et al. Platelet kinetics with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood 65 (1985) 584-588
12. Ballem P.J., Segal G.M., Stratton J.R., et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 80 (1987) 33-40
13. Gernsheimer T., Stratton J., Ballem P.J., et al. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N Engl J Med 320 (1989) 974-980
14. McMillan R., Wang L., Tomer A., et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103 (2004) 1364-1369
15. Chang M., Nakagawa P.A., Williams S.A., et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 102 (2003) 887-895
16. Kuwana M., Kaburaki J., and Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 102 (1998) 1393-1402
17. Semple J.W. Pathogenic T-cell responses in patients with autoimmune thrombocytopenic purpura. J Pediatr Hematol Oncol 25 Suppl 1 (2003) S11-S13
18. Stasi R., Cooper N., Del Poeta G., et al. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood 112 (2008) 1147-1150
19. Cines D.B., and Blanchette V.S. Immune thrombocytopenic purpura. N Engl J Med 346 (2002) 995-1008
20. Liebman H.A., and Stasi R. Secondary immune thrombocytopenic purpura. Curr Opin Hematol 14 (2007) 557-573
21. Stasi R., Sarpatwari A., Segal J.B., et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 113 (2009) 1231-1240
22. Cines D.B., Bussel J.B., Liebman H.A., et al. The ITP syndrome: a diverse set of disorders with different immune mechanisms. Blood 113 (2009) 6511-6521
23. Rodeghiero F., Stasi R., Gernsheimer T., et al. Standardization of terminology, definitions and decisional criteria in immune thrombocytopenic purpura (ITP) in adults and children. Report from an International Working Group. Blood 113 (2009) 2386-2393